![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2021\/10\/FDA-heads-become-big-pharma-execs-1024x692.jpg\")
<\/p>\nWRITTEN BY: TIM BROWN
\nSons of Liberty<\/p>\n
<\/p>\n
The Food and Drug Administration is completely not authorized in the US Constitution and for good reason.\u00a0 The conflicts of interest and opportunity for corruption is tremendous.\u00a0 Don\u2019t believe me?\u00a0 I\u2019ll give you three good reasons:\u00a0All 3 FDA-authorized COVID shot companies now employ former FDA commissioners.<\/p>\n
Jordan Schachtel<\/a>\u00a0has the story.<\/p>\n Have an experimental drug that needs rapid authorization from the FDA in order to be sold to the masses? Looking to siphon billions of dollars from the U.S. taxpayer for your newfound pharmaceutical product? In today\u2019s America, you can buy yourself a former FDA commissioner, and use the public-sector private-sector revolving door system of corruption to impose your will on the American public, and make a windfall for your executives and shareholders in the process.<\/em><\/p>\n That appears to be the exact strategy utilized by Johnson & Johnson, Pfizer, and the company that founded Moderna, which have rostered a series of former top ranking government officials into top positions in their respective organizations.<\/em><\/p>\n Former FDA Commissioner\u00a0Scott Gottlieb<\/strong>,\u00a0the ultimate personification of the revolving door<\/a>\u00a0mechanism, sits on the board of Pfizer. The frequent Pfizer-sponsored CNBC guest also maintains several thousand shares of Pfizer stock, and he is compensated well into the six figures on an annual basis. Gottlieb earns\u00a0millions<\/a>\u00a0from his continually increasing board appointments to a plethora of pharmaceutical and healthcare companies.<\/em><\/p>\n The pandemic profiteer also sits on the boards of Illumina and Tempus Labs, which sell FDA-authorized COVID-19 test kits. Additionally, he sits on the board of Aetion, which has\u00a0partnered<\/a>\u00a0with the FDA on researching COVID-19 policy.<\/em><\/p>\n Stephen Hahn<\/strong>, who led the FDA when it authorized Moderna\u2019s COVID shots, recently took an executive level post with\u00a0Flagship Pioneering<\/a>, the company that launched Moderna. Flagship holds 20 million shares of Moderna stock, which as of October 16, 2021, is valued at $6.5 Billion. They\u00a0earned<\/a>\u00a0$1.4 billion through the sale of Moderna stock earlier this year.<\/em><\/p>\n There is virtually no separation between Flagship and Moderna. Flagship CEO Noubar Afeyan, who co-founded Moderna and owns over 2 million shares of Moderna stock, is the current chairman of Moderna. Additionally, Moderna CEO St\u00e9phane Bancel is listed as a Flagship \u201cspecial partner<\/a>.\u201d<\/em><\/p>\n<\/div>\nDr. Scott Gottlieb<\/em><\/h2>\n
Dr. Stephen Hahn<\/em><\/h2>\n